
US drug deaths plunged in 2024. Trump cuts may reverse that, experts warn.
The progress comes after drug deaths, which had been rising for more than a decade, soared to staggering levels during the coronavirus pandemic, surpassing 100,000 each year starting in 2021.
Get Starting Point
A guide through the most important stories of the morning, delivered Monday through Friday.
Enter Email
Sign Up
'I would characterize this as a historically significant decrease in overdose deaths,' said Brandon Marshall, a Brown University School of Public Health epidemiologist who studies overdose trends. 'We're really seeing decreases almost across the entire nation at this point.'
The data published Wednesday charts a dramatic decline in deaths during then-President Joe Biden's final year in office. The Trump administration has espoused hard-line rhetoric on fentanyl, declaring traffickers a top national security threat and citing them as a key reason for launching trade battles with China and allies Canada and Mexico.
The administration has also touted large fentanyl seizures and asked Mexico to allow the US military to conduct counternarcotics operations on Mexican soil, a request denied by that country's president.
Advertisement
The CDC, in a statement, noted that Trump during his first administration declared the opioid crisis a public-health emergency in 2017. The declines since 2023 are a 'strong sign that public health interventions are making a difference and having a meaningful impact,' the agency said. 'Despite these overall improvements, overdose remains the leading cause of death for Americans aged 18-44, underscoring the need for ongoing efforts to maintain this progress.'
The White House Office of National Drug Control Policy, in an April statement of policy priorities, emphasized curbing the flow of illicit fentanyl, along with expanding access to treatment and research into cutting-edge technologies to identify and address emerging drug threats.
But public health advocates are raising alarm that the Trump administration is undercutting those goals with plans to gut federal funding that helps states pay for overdose antidotes, addiction treatment and other measures. A survey conducted by the nonprofit research firm Rand published in May suggests that more people may be using illicit opioids than previously estimated, underscoring the need for better monitoring.
In a letter to Congress on Monday, more than 300 academics warned that the Trump administration's proposed cuts to the Substance Abuse and Mental Health Services Administration and CDC could 'undermine the hard-fought progress we have made, especially in overdose prevention.'
Experts also worry Republican plans to slash Medicaid could leave former drug users without access to medication, forcing them to turn to street drugs, said Chad Sabora, a drug policy expert who helped organize the letter. 'It will equal more people dying,' he said.
Advertisement
What explains the drop?
The opioid crisis began decades ago with highly addictive prescription pain killers flooding states. Users later turned to cheaper street heroin, which was largely replaced by fentanyl manufactured by Mexican organized crime groups with precursor chemicals sourced from China. The synthetic drug can be up to 50 times more potent than heroin.
No single reason explains the sudden drop in deaths, researchers and health officials stress.
The Biden administration credited seizures of fentanyl at the southern border, arrests of high-level Mexican drug traffickers and cooperation from Beijing to crack down on unscrupulous Chinese companies exporting precursor chemicals. The administration also expanded access to addiction treatment medications such as buprenorphine, which wards off opioid withdrawals, and the overdose reversal drug naloxone. It also embraced harm reduction organizations that have saturated communities with free naloxone, fentanyl test strips and sterile needles to users.
Fewer deaths 'don't just happen overnight. And that's why we can credit them to the Biden administration's work,' said Sheila P. Vakharia, deputy director of research and academic engagement for the nonprofit Drug Policy Alliance.
Experts also believe that
the illicit drug supply, at least in some regions, may be shifting to include less fentanyl. Other drugs added to fentanyl - such as the tranquilizer xylazine - may prolong the sedating effect and
stave off opioid withdrawal so that users consume less fentanyl each day, researchers theorize.
Declines in deaths may also reflect the grim reality that fentanyl has killed so many regular users that there are fewer people at risk of overdose. The trajectory of deaths 'can't keep going up. It has essentially to kind of burn itself out,' said Caleb Banta-Green, an addiction expert and drug researcher at the University of Washington School of Medicine.
Advertisement
During Biden's first three years, the death toll topped 100,000 each year.
Deaths during a 12-month period peaked in June 2023 at a staggering 114,670, making the rapid drop nationally all the more remarkable, said Nabarun Dasgupta, an epidemiologist at the University of North Carolina at Chapel Hill. He stressed that deaths had been falling in certain regions where fentanyl had been entrenched for longer.
'Americans have responded to the overdose crisis with powerful community efforts, from every small town to large city. What we are seeing is the fruit of all that collective labor. These local efforts are the heart of overdose prevention,' Dasgupta said.
A state-by-state look
The CDC data released on Wednesday is not definitive; final death statistics lag because toxicology testing often takes months to complete.
Deaths involving stimulants such as methamphetamine and cocaine - which users increasingly take alongside fentanyl - also decreased, the statistics show.
Two states, Nevada and South Dakota notched slight increases from the previous year. But nearly all states showed declines in 2024. States such as New Hampshire, West Virginia and Ohio recorded declines of 35 percent or more.
In Washington state, where fentanyl became entrenched years later than on the East Coast, suspected drug deaths dropped by nearly 12 percent, after years of increases, for a total of 3,167.
In King County, home to Seattle, health officials distributed 124,700 naloxone kits in 2024 and opened three vending machines for people to obtain the medication, fentanyl test strips and other supplies.
County officials and the University of Washington Department of Emergency Medicine also debuted a hotline for doctors to prescribe buprenorphine through free telehealth sessions at any time of day. The city's mayor in August announced an investment of nearly $3 million in opioid litigation settlement money to increase capacity for inpatient treatment.
Advertisement
But the state health department's top medical officer, Tao Kwan-Gett, urged cautioned. Washington overdose deaths fell through much of 2024 but spiked during the final four months of the year.
'It's too early to say that we're seeing a sustained decrease,' Kwan-Gett said. 'I certainly hope we are, but I think we have to continue being vigilant.'
The encouraging statistics in Washington and nationwide belie the heartbreak of addiction - and death.
Among the victims nationwide in 2024: a 17-month-old Los Angeles boy who ingested fentanyl during a child welfare-monitored visit with his mother; a 15-year-old girl who fatally overdosed on fentanyl at her Georgia high school, nine people who fatally overdosed in Austin, during one day.
In Seattle, former movie set designer Wade Paradise battled an opioid addiction for years after taking prescription pain killers. He was largely estranged from his family, living in squalor and suffering from myriad ailments, according to his daughter, Nathalie Paradise, 24.
She said Wade Paradise had struggled to get addiction treatment because of problems with health insurance. In December, he died at age 68 in his home from a pill made of fentanyl. His death received little attention but for Nathalie's GoFundMe page in which she recalled cherished childhood memories of summer swims in a lake and bargain hunting at thrift stores - and detailed his addiction.
'I didn't want it to be a secret anymore. I felt like the people in his life deserved to know the truth,' she said in an interview. 'I also have a lot of friends who use drugs, and I hoped that by sharing my story, it might encourage them to stop.'
Advertisement
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Newsweek
an hour ago
- Newsweek
Travel Warning Issued for China Amid Mosquito-Borne Virus Outbreak
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. The U.S. Centers for Disease Control and Prevention (CDC) issued a Level 2 travel alert on Friday, advising those planning to visit China to practice enhanced precautions due to a significant chikungunya virus outbreak. Newsweek has reached out to the CDC via media inquiry form Saturday during non-working hours. Why It Matters Chikungunya is a viral disease transmitted primarily by Aedes mosquitoes and can cause symptoms such as fever, joint pain, headache, muscle pain, joint swelling, and rash. While symptoms can be severe and occasionally last for months, most cases resolve without hospitalization or death. There is currently no specific antiviral medicine for chikungunya, so treatment focuses on managing symptoms. The CDC advisory followed a surge in infections in southern China, raising concerns about travelers unknowingly importing the mosquito-borne illness to new regions. The outbreak highlights the persistent challenges posed by emerging infectious diseases in a highly connected world and the importance of prevention for U.S. travelers to affected destinations. What To Know The CDC's Level 2 alert—designated as "Practice Enhanced Precautions"—was announced after Chinese health authorities reported nearly 5,000 chikungunya infections, primarily in Guangdong province. The outbreak began in early July, with over 3,000 cases identified in a single week. In Foshan, a major manufacturing city in Guangdong, local officials accounted for about 60 percent of the reported cases. As of July 30, the total number of documented cases in Guangdong surpassed 6,500, with most classified as mild and no deaths reported by regional health authorities, the South China Morning Post reported on Saturday. The Aedes mosquitos bite during the daytime and patients can see symptoms anywhere from three to seven days after being bitten by an infected mosquito. The CDC has warned that internationally mobile travelers may further spread the virus to regions where it has not previously circulated. On Saturday, the first imported case since 2019 was reported in Hong Kong in a child who spent two weeks in Shunde district, the South China Morning Post reported. Chinese Vice-Premier Liu Guozhong urged local authorities in Foshan to "strictly implement port health quarantine measures," and called for heightened mosquito control efforts to "effectively eliminate mosquitoes and cut off epidemic spread channels," according to China's official Xinhua News Agency. Officials have released thousands of mosquito-eating fish in the Guangdong province in an effort to curb the rising number of cases, according to a report from state-run media outlet China Daily. Because no specific antiviral medicine is available for chikungunya, prevention—through vaccination, insect repellent, long sleeves, and mosquito control measures—remains the most effective defense, according to the CDC. Globally, the European Centre for Disease Prevention and Control reported that chikungunya has affected approximately 240,000 people and caused 90 deaths across at least 16 countries so far this year. The mortality rate for chikungunya remains low and fatalities are rare. This photograph shows a mosquito trap as part of the fight against the Chikungunya pandemic by mosquitoes in Saint-Benoit on the French overseas island of La Reunion on April 22. This photograph shows a mosquito trap as part of the fight against the Chikungunya pandemic by mosquitoes in Saint-Benoit on the French overseas island of La Reunion on April 22. Photo by LUDOVIC MARIN/AFP via Getty Images What People Are Saying The World Health Organization (WHO) said on its website: "Chikungunya is a mosquito-borne viral disease that causes fever and severe joint pain. It is caused by a ribonucleic acid (RNA) virus that belongs to the alphavirus genus of the family Togaviridae." It continued: "The name 'chikungunya' derives from a word in the Kimakonde language of southern Tanzania, meaning "that which bends up" and describes the stooped appearance of infected people with severe joint pain (arthralgia)." U.S. Centers for Disease Control and Prevention (CDC) said on its website: "Outbreaks have occurred in Africa, the Americas, Asia, Europe, and islands in the Indian and Pacific Oceans. There is a risk the virus can spread to unaffected areas by infected travelers." What Happens Next? Travelers to affected areas of China are advised by the CDC to practice enhanced protective measures against mosquito bites, including using EPA-registered insect repellent and staying in accommodations with window screens or air conditioning. Chinese public health officials have stepped up surveillance and vector control campaigns in Foshan and Guangdong, seeking to contain the spread and prevent the escalation of severe cases.

Epoch Times
an hour ago
- Epoch Times
Trump Admin Restores Long‑Standing Ban on Taxpayer‑Funded Abortions at VA Hospitals
The Trump administration has announced a proposal to rescind a Biden-era rule and bar medical centers operated by the Department of Veterans Affairs (VA) from performing taxpayer-funded abortions except when the mother's life is in danger. The regulatory change will be formally proposed by VA in the Aug. 4 edition of the Federal Register, with a 30-day public comment period before it can enter into force.


New York Post
2 hours ago
- New York Post
Why many women over age 52 have a higher risk of getting STIs
STIs are on the rise — but it's not just frat bros and free-lovers feeling the burn. While younger people still account for the majority of cases, studies show that some of the steepest spikes are happening in people 55 and up. Experts have offered several explanations for the surge, but research suggests there's a risk factor affecting many midlife and older women that has largely flown under the radar and could be playing a key role. Advertisement 4 More Americans are having sex in their senior years thanks to advancements in medicine. Monkey Business – More than a million American women hit menopause each year — and it's not just hot flashes and mood swings they're facing. The transition, which wraps up around age 52 on average, marks the end of reproductive years and is driven by a drop in estrogen as the ovaries slow hormone production. While vaginal dryness and loss of elasticity are well-known symptoms, research from Ohio State University (OSU) shows that menopause can also weaken the vaginal tissue itself, making it more prone to tearing. Advertisement That vulnerability comes down to changes at the cellular level. The vagina's surface is made up of multiple layers held together by key proteins like desmoglein-1 (DSG1) and desmocollin-1 (DSC1). 'These proteins strengthen the vaginal lining and restrict pathogen access to deeper tissue, reducing the risk of infection,' Dr. Thomas L. Cherpes, associate professor of otolaryngology at OSU, wrote in The Conversation. Advertisement 4 Menopause can bring a host of uncomfortable symptoms, including vaginal changes. – In their research, Cherpes and his colleagues found that postmenopausal women have significantly lower levels of DSG1 and DSC1 than women who haven't gone through the transition. To see how this might impact infection risk, the researchers removed the ovaries of mice in a lab to mimic estrogen loss in postmenopausal women. Compared to mice with intact ovaries, those without had far lower levels of DSG1 and DSC1 in their vaginal tissue. Advertisement The team also found that these mice were more vulnerable to infection with herpes simplex virus type 2 (HSV-2), which causes genital herpes. They were less able to clear chlamydia infections from the lower genital tract as well. The findings help explain why postmenopausal women are more susceptible to STIs than their younger counterparts. Notably, when Cherpes and his colleagues applied estrogen cream to the mice without ovaries, it restored the vaginal lining's integrity and fully protected them from HSV-2 infection. 4 The vaginal tissue is more vulnerable to tearing after menopause, opening the door to infection. megaflopp – 'While additional research is needed, findings from our lab suggest that estrogen-containing compounds used to relieve vaginal irritation and other symptoms of genitourinary syndrome of menopause can also reduce susceptibility to STIs among older adults,' Cherpes wrote. Sex doesn't stop — and neither do the risks Americans might not like to talk about it, but older adults are still very much having sex. A 2018 survey found nearly 40% of people aged 65 to 80 are sexually active, and almost two-thirds remain interested in sex. Advertisement More recent AARP data shows that 26% of 60- to 69-year-olds and 17% of those 70 and older have sex weekly. 'Hormone-replacement therapy, vaginal lubricants and the approval of sildenafil (Viagra) and its relatives have extended people's sex lives,' Dr. Sandra Adamson Fryhofer told the American Medical Association. But while more people are living longer and staying sexually active, more are also paying the price. 4 Sex-crazed seniors are fueling a major spike in STIs nationwide. David – Advertisement 'Rates are highest in the under 25 age group, which accounts for about 50% of STIs, but we're definitely seeing a rise in infections in the older population, particularly in people over 65,' Dr. Angelina Gangestad said in an interview with University Hospitals. Between 2010 and 2023, the number of Americans over 65 diagnosed with chlamydia, gonorrhea or syphilis rose by roughly three-, five- and sevenfold, respectively, according to the Centers for Disease Control and Prevention. Research also suggests women over 50 are at greater risk for HIV than their younger peers. Advertisement In addition to the effects of menopause, experts say several other factors are likely fueling the rise. Condom use is significantly lower among older adults compared to younger people. One study found that just 3% of Americans aged 60 and older have used a condom in the past year. Older adults also tend to have less knowledge about STIs, including how they spread, what symptoms look like and how to prevent them. Advertisement To make matters worse, research suggests that many doctors don't ask older patients about their sex lives — and seniors aren't exactly jumping to bring it up with their family or friends, either. 'No one wants to think about grandma doing this,' Matthew Lee Smith, an associate professor at the Texas A&M School of Public Health, told NBC News. 'You certainly aren't going to ask grandma if she was wearing condoms — and that's part of the problem, because every individual regardless of age has the right to intimacy.'